China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Financial Flexibility Index
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥428.73 Million (operating CF CN¥126.71 Million minus capex CN¥302.02 Million) represents 0% of total liabilities (CN¥19.18 Billion). Check how aggressively does China Resources Sanjiu Medical & Pharmac reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see China Resources Sanjiu Medical & Pharmac cash flow conversion.
Annual Financial Flexibility Index for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year free cash flow to debt coverage for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. Explore 000999 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | CN¥5.19 Billion | CN¥4.40 Billion | CN¥14.83 Billion | ▲ +9.6% |
| 2023 | 0.32x | CN¥5.08 Billion | CN¥4.22 Billion | CN¥15.89 Billion | ▼ -22.6% |
| 2022 | 0.41x | CN¥3.96 Billion | CN¥3.01 Billion | CN¥9.59 Billion | ▲ +29.4% |
| 2021 | 0.32x | CN¥2.74 Billion | CN¥1.87 Billion | CN¥8.60 Billion | ▼ -10.9% |
| 2020 | 0.36x | CN¥2.85 Billion | CN¥2.22 Billion | CN¥7.95 Billion | ▲ +3.1% |
| 2019 | 0.35x | CN¥2.51 Billion | CN¥1.97 Billion | CN¥7.22 Billion | ▼ -5.1% |
| 2018 | 0.37x | CN¥2.51 Billion | CN¥1.91 Billion | CN¥6.86 Billion | ▲ +14.8% |
| 2017 | 0.32x | CN¥1.94 Billion | CN¥1.56 Billion | CN¥6.07 Billion | ▼ -11.8% |
| 2016 | 0.36x | CN¥1.75 Billion | CN¥1.39 Billion | CN¥4.83 Billion | ▼ -1.2% |
| 2015 | 0.37x | CN¥1.59 Billion | CN¥1.26 Billion | CN¥4.35 Billion | ▼ -11.9% |
| 2014 | 0.42x | CN¥1.53 Billion | CN¥1.18 Billion | CN¥3.67 Billion | ▼ -11.5% |
| 2013 | 0.47x | CN¥1.82 Billion | CN¥1.47 Billion | CN¥3.88 Billion | ▼ -16.9% |
| 2012 | 0.57x | CN¥1.72 Billion | CN¥1.21 Billion | CN¥3.04 Billion | ▲ +13.8% |
| 2011 | 0.50x | CN¥1.36 Billion | CN¥954.90 Million | CN¥2.75 Billion | ▼ -27.7% |
| 2010 | 0.69x | CN¥1.12 Billion | CN¥848.28 Million | CN¥1.63 Billion | ▲ +10.2% |
| 2009 | 0.62x | CN¥1.05 Billion | CN¥855.05 Million | CN¥1.68 Billion | ▼ -55.9% |
| 2008 | 1.42x | CN¥2.32 Billion | CN¥1.12 Billion | CN¥1.64 Billion | ▲ +731.8% |
| 2007 | 0.17x | CN¥832.07 Million | CN¥605.30 Million | CN¥4.89 Billion | ▲ +36.7% |
| 2006 | 0.12x | CN¥561.32 Million | CN¥425.51 Million | CN¥4.51 Billion | ▲ +865.4% |
| 2005 | 0.01x | CN¥59.97 Million | CN¥22.83 Million | CN¥4.65 Billion | ▲ +109.9% |
| 2004 | -0.13x | CN¥-635.05 Million | CN¥-719.63 Million | CN¥4.89 Billion | ▼ -512.1% |
| 2003 | 0.03x | CN¥163.97 Million | CN¥28.09 Million | CN¥5.20 Billion | ▼ -81.4% |
| 2002 | 0.17x | CN¥668.80 Million | CN¥496.12 Million | CN¥3.95 Billion | ▲ +126.9% |
| 2001 | 0.07x | CN¥272.26 Million | CN¥153.44 Million | CN¥3.65 Billion | ▼ -50.3% |
| 2000 | 0.15x | CN¥437.44 Million | CN¥266.86 Million | CN¥2.91 Billion | ▼ -28.3% |
| 1999 | 0.21x | CN¥194.06 Million | CN¥120.63 Million | CN¥925.96 Million | — |